drugset / Trial / NCT03782103

In-vivo Efficacy of Patient Preoperative Prep, ZuraPrep (ZP)

NCT03782103

Phase 3 Completed 156 enrolled Zurex Pharma, Inc.
RandomizedParallel-groupSingle-blindPrevention

Summary

The objective of the study is to demonstrate the antimicrobial efficacy of the Zurex Preoperative Prep (ZuraPrep - clear) on skin flora of the abdomen and inguinal regions of human subjects.

Timeline

Start
2019-01-25
Primary completion
2019-05-12
Completion
2019-09-26

Drugs

EvaluationDrugModalityDoseRoute
Comparator Chlorhexidine Small molecule 2 % Topical
Comparator Chlorhexidine Small molecule 70 % Topical
Subject Isopropyl alcohol Other / unclassified 70 % Topical

Indications

No indication recorded.